Literature DB >> 12468271

Newborn screening: rationale for a comprehensive, fully integrated public health system.

Linda L McCabe1, Bradford L Therrell, Edward R B McCabe.   

Abstract

Newborn screening has existed for approximately four decades. During that period of time, newborn screening has evolved conceptually from a laboratory test for a single disorder, phenylketonuria (PKU), to a multi-part public health system involving education, screening, diagnostic follow-up, treatment/management, and system evaluation. At a time when newborn screening is recognized as a model for predictive medicine, it also faces critical challenges that will determine its future credibility and viability. In order to understand these challenges, it is helpful to review briefly the history of newborn screening.

Entities:  

Mesh:

Year:  2002        PMID: 12468271     DOI: 10.1016/s1096-7192(02)00196-8

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Newborn screening in the Asia Pacific region.

Authors:  Carmencita D Padilla; Bradford L Therrell
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

2.  Neonatal screening: from the 'Guthrie age' to the 'genetic age'.

Authors:  Jean-Louis Dhondt
Journal:  J Inherit Metab Dis       Date:  2007-05-12       Impact factor: 4.982

3.  Newborn screening in Canada - Are we out of step?

Authors:  William B Hanley
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

Review 4.  Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing.

Authors:  Stephen F Kingsmore; Darrell L Dinwiddie; Neil A Miller; Sarah E Soden; Carol J Saunders
Journal:  Expert Rev Mol Diagn       Date:  2011-11       Impact factor: 5.225

Review 5.  Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example.

Authors:  Kathryn M Camp; Michele A Lloyd-Puryear; Kathleen L Huntington
Journal:  Mol Genet Metab       Date:  2012-07-16       Impact factor: 4.797

6.  Empowering newborn screening programs in African countries through establishment of an international collaborative effort.

Authors:  Bradford L Therrell; Michele A Lloyd-Puryear; Kwaku Ohene-Frempong; Russell E Ware; Carmencita D Padilla; Emmanuela E Ambrose; Amina Barkat; Hassan Ghazal; Charles Kiyaga; Tisungane Mvalo; Obiageli Nnodu; Karim Ouldim; Mohamed Chérif Rahimy; Brígida Santos; Léon Tshilolo; Careema Yusuf; Guisou Zarbalian; Michael S Watson
Journal:  J Community Genet       Date:  2020-05-15

Review 7.  The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review.

Authors:  Ashraf El-Metwally; Lujane Yousef Al-Ahaidib; Alaa Ayman Sunqurah; Khaled Al-Surimi; Mowafa Househ; Ali Alshehri; Omar B Da'ar; Hira Abdul Razzak; Ali Nasser AlOdaib
Journal:  Biomed Res Int       Date:  2018-04-18       Impact factor: 3.411

8.  Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis.

Authors:  Mehdi Shokri; Parviz Karimi; Hadis Zamanifar; Fatemeh Kazemi; Gholamreza Badfar; Milad Azami
Journal:  BMC Pediatr       Date:  2020-07-24       Impact factor: 2.125

9.  Clinical, genetic and microbiological characterization of pediatric patients with cystic fibrosis in a public Hospital in Ecuador.

Authors:  Yazmina Lascano-Vaca; Esteban Ortiz-Prado; Lenin Gomez-Barreno; Katherine Simbaña-Rivera; Eduardo Vasconez; Alexander Lister; María Emilia Arteaga-Espinosa; Geovanny F Perez
Journal:  BMC Pediatr       Date:  2020-03-06       Impact factor: 2.125

10.  Epidemiology of Phenylketonuria Disease in Jordan: Medical and Nutritional Challenges.

Authors:  Safwan Dababneh; Mohammed Alsbou; Nashat Taani; Ghazi Sharkas; Refqi Ismael; Latifeh Maraqa; Omar Nemri; Hanin Al-Jawaldeh; Nadeen Kopti; Enas Atieh; Arab Almasri
Journal:  Children (Basel)       Date:  2022-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.